about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerDifferential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomesPregnane X receptor and yin yang 1 contribute to the differential tissue expression and induction of CYP3A5 and CYP3A4.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Drug metabolism by tumours: its nature, relevance and therapeutic implications.Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.An evaluation of the latest in vitro tools for drug metabolism studies.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.Cytochrome P450 CYP1B1 activity in renal cell carcinoma.The effect of N-acetylcysteine on the antitumor activity of ifosfamide.Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.Antiproliferative effect of the Ginkgo biloba extract is associated with the enhancement of cytochrome P450 1B1 expression in estrogen receptor-negative breast cancer cellsSide chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
P2860
Q21090644-07328C9D-6766-4343-82BB-D7AFC55ADE80Q28567676-92D305A2-6552-4A9B-806C-DE74A77DD2F4Q34146529-FA1831F2-A42F-482B-AE2C-CEAB8D073F47Q34204238-9C4A6476-2F68-4249-88CE-8D3EB7B177A0Q35637852-8BFD9327-3620-4C41-BB92-FE60F0A50BBCQ35962274-82BFCB38-8DFA-47CE-9304-4B7E425FA74FQ37008879-53B81803-28FA-4D9B-BDFB-021DC36F7080Q37037051-5655C549-D3B5-4EB7-B81A-139C9CAC5C61Q38160881-881962E3-F589-459B-BDF4-8208F21E38B6Q38163945-F3BBE3E0-7D15-43D6-81B8-F5FAFD4024D0Q38787174-9FB2E0D3-BF51-4CB7-8600-49ACA7A5EFA3Q38800931-91EDBFAC-F0B8-4EA9-88B7-55CF9623AAFAQ39537262-7F3C4A70-2337-4615-BDFB-91A552A9F5F4Q39916257-06699C93-F92D-4304-A1C0-A1C39B3A5232Q41928184-994B6088-2376-4A17-8E7B-8979C63986E4Q43675409-0B01763B-4394-4C32-84DC-088CA6C9F68BQ44445808-082DBAEE-F554-4662-82F3-F9D804DFE021Q50179674-B35B5164-AB45-45C7-95AE-A43C56370D80Q50971441-EA8BBDC2-9118-4EC8-BE93-FD86FD656771
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cytochrome P450 CYP3A in human renal cell cancer.
@ast
Cytochrome P450 CYP3A in human renal cell cancer.
@en
type
label
Cytochrome P450 CYP3A in human renal cell cancer.
@ast
Cytochrome P450 CYP3A in human renal cell cancer.
@en
prefLabel
Cytochrome P450 CYP3A in human renal cell cancer.
@ast
Cytochrome P450 CYP3A in human renal cell cancer.
@en
P2093
P2860
P356
P1476
Cytochrome P450 CYP3A in human renal cell cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690292
P407
P577
1999-04-01T00:00:00Z